Min Han
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 15
- Advanced biosensing and bioanalysis techniques 10
-
- Nanoplatforms for cancer theranostics 17
- Co-authors
- Jianqing Gao (43 shared papers)Qichun Wei (17 shared papers)Jiejian Chen (14 shared papers)Ningning Guo (10 shared papers)Yi Zhou (13 shared papers)Qiyao Yang (18 shared papers)Yulan Hu (7 shared papers)Mengting Lin (17 shared papers)
- Journals
- International Journal of Pharmaceutics (7 papers)International Journal of Nanomedicine (7 papers)Molecular Pharmaceutics (6 papers)ACS Applied Materials & Interfaces (5 papers)Journal of Controlled Release (4 papers)
- Partner nations
- ChinaJapanSouth Korea
In The Last Decade
Min Han
99 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Biomaterials 1.0k
- Pharmaceutical Science 245
- Molecular Biology 1.4k
- Biomedical Engineering 906
- Cancer Research 297
Countries citing papers authored by Min Han
This map shows the geographic impact of Min Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Han more than expected).
Fields of papers citing papers by Min Han
This network shows the impact of papers produced by Min Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Han. The network helps show where Min Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy Hit paper breakdown → | 2020 | 315 |
| 2 | 2014 | 199 | |
| 3 | 2013 | 179 | |
| 4 | 2012 | 139 | |
| 5 | 2015 | 113 | |
| 6 | 2022 | 101 | |
| 7 | 2017 | 100 | |
| 8 | 2011 | 87 | |
| 9 | 2014 | 77 | |
| 10 | 2015 | 76 | |
| 11 | 2006 | 70 | |
| 12 | 2019 | 61 | |
| 13 | 2019 | 60 | |
| 14 | 2018 | 60 | |
| 15 | 2018 | 55 | |
| 16 | 2006 | 51 | |
| 17 | 2016 | 49 | |
| 18 | 2022 | 48 | |
| 19 | 2013 | 47 | |
| 20 | 2020 | 45 |
About Min Han
Min Han is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Oncology and Pharmaceutical Science, having authored 103 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Nanoplatforms for cancer theranostics (17 papers), RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Boron Compounds in Chemistry (7 papers), Advanced Drug Delivery Systems (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). The work is most often cited by research in Biomaterials (1.0k citations), Pharmaceutical Science (245 citations), Molecular Biology (1.4k citations), Biomedical Engineering (906 citations) and Cancer Research (297 citations). Min Han has collaborated with scholars based in China, Japan and South Korea. Frequent co-authors include Jianqing Gao, Qichun Wei, Jiejian Chen, Ningning Guo, Yi Zhou, Qiyao Yang, Yulan Hu, Mengting Lin, Fanzhu Li and Ming-Yi Huang-Fu. Their work appears in journals such as International Journal of Pharmaceutics, International Journal of Nanomedicine, Molecular Pharmaceutics, ACS Applied Materials & Interfaces and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.